Tags

Type your tag names separated by a space and hit enter

Contraceptive Steroids, age, and the cardiovascular system.
Am J Obstet Gynecol. 1982 Mar 15; 142(6 Pt 2):747-51.AJ

Abstract

There is evidence that women who use oral contraceptives may be at slightly greater risk of cardiovascular complications as their age increased beyond 35 years. Popular opinion has held that these risks were largely estrogen-related. At the same time, however, postmenopausal women taking natural estrogen alone or in association with minimal amounts of progestogen have not exhibited these increased risk when compared with untreated control subjects. New clinical data indicate that there is a progestogen dose-related decrease in high-density lipoprotein cholesterol. There is also some evidence that relates progestogen dosage to morbidity rates from circulatory disease. Therefore the smallest dose of both estrogen and progestogen consistent with contraceptive efficacy and reasonable cycle control must be sought for all steroid combinations. This applies particularly to oral contraception for the woman beyond 35 years of age.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

7065055

Citation

Plunkett, E R.. "Contraceptive Steroids, Age, and the Cardiovascular System." American Journal of Obstetrics and Gynecology, vol. 142, no. 6 Pt 2, 1982, pp. 747-51.
Plunkett ER. Contraceptive Steroids, age, and the cardiovascular system. Am J Obstet Gynecol. 1982;142(6 Pt 2):747-51.
Plunkett, E. R. (1982). Contraceptive Steroids, age, and the cardiovascular system. American Journal of Obstetrics and Gynecology, 142(6 Pt 2), 747-51.
Plunkett ER. Contraceptive Steroids, Age, and the Cardiovascular System. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):747-51. PubMed PMID: 7065055.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Contraceptive Steroids, age, and the cardiovascular system. A1 - Plunkett,E R, PY - 1982/3/15/pubmed PY - 1982/3/15/medline PY - 1982/3/15/entrez KW - Age Factors KW - Biology KW - Cardiovascular Effects KW - Contraception KW - Contraceptive Agents KW - Contraceptive Agents, Estrogen KW - Contraceptive Agents, Female KW - Contraceptive Agents, Progestin KW - Contraceptive Methods--side effects KW - Demographic Factors KW - Family Planning KW - Female Sterilization KW - Menopause KW - Mortality KW - Oral Contraceptives--side effects KW - Physiology KW - Population KW - Population Characteristics KW - Population Dynamics KW - Treatment SP - 747 EP - 51 JF - American journal of obstetrics and gynecology JO - Am J Obstet Gynecol VL - 142 IS - 6 Pt 2 N2 - There is evidence that women who use oral contraceptives may be at slightly greater risk of cardiovascular complications as their age increased beyond 35 years. Popular opinion has held that these risks were largely estrogen-related. At the same time, however, postmenopausal women taking natural estrogen alone or in association with minimal amounts of progestogen have not exhibited these increased risk when compared with untreated control subjects. New clinical data indicate that there is a progestogen dose-related decrease in high-density lipoprotein cholesterol. There is also some evidence that relates progestogen dosage to morbidity rates from circulatory disease. Therefore the smallest dose of both estrogen and progestogen consistent with contraceptive efficacy and reasonable cycle control must be sought for all steroid combinations. This applies particularly to oral contraception for the woman beyond 35 years of age. SN - 0002-9378 UR - https://www.unboundmedicine.com/medline/citation/7065055/Contraceptive_Steroids_age_and_the_cardiovascular_system_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9378(16)32482-6 DB - PRIME DP - Unbound Medicine ER -